News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eisai Company, Ltd. (ESALY.PK) Loses Lawsuit Against DEA Over Scheduling Epilepsy Pill


10/25/2013 7:28:41 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A setback to Eisai that also raises questions for the pharmaceutical industry, a federal appeals court has dismissed a lawsuit the drugmaker filed against the US Drug Enforcement Agency for failing to schedule its Fycompa epilepsy pill as a controlled substance. Eisai charged the DEA with “unreasonably” and “egregiously” delaying what “historically, has been a straightforward, relatively simple task.” As we noted at the time the lawsuit was filed last August, the pill was approved by the FDA a year ago and a scheduling recommendation was sent in January.

Help employers find you! Check out all the jobs and post your resume.

Read at Pharmalot


comments powered by Disqus
Pharmalot
   
Epilepsy

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES